ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Key Hearings Scheduled On Cancer Act, Appropriations

January 21, 1977

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

April 27, 2012

Statement Defining Cancer Control Goals, Approaches Okayed By Board

February 6, 1981

Cervical Screening Should Emphasize Older Women, ASP Members Told

March 14, 1986

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012